Article
Commentary: Concomitant Therapies May Affect NSCLC Survival, August 2022
- Author:
- Jonathan W. Riess, MD, MS
Publish date: August 11, 2022
Article
Commentary: New Horizons in NSCLC Treatment: Adagrasib, Aumolertinib, and Lorlatinib, July 2022
- Author:
- Jonathan W. Riess, MD, MS
Publish date: July 1, 2022
Article
Commentary: Genetic Components of NSCLC, June 2022
- Author:
- Jonathan W. Riess, MD, MS
Publish date: June 1, 2022
Article
Clinical Edge Journal Scan Commentary: Recent Lung Cancer Trial Results, May 2022
- Author:
- Jonathan W. Riess, MD, MS
Publish date: May 3, 2022